Transferrin-Targeted Nanoparticles Containing Zoledronic Acid as a Potential Tool to Inhibit Glioblastoma Growth.

Salzano, G; Zappavigna, S; Luce, A; D'Onofrio, N; Balestrieri, M L; Grimaldi, A; Lusa, S; Ingrosso, D; Artuso, S; Porru, M; Leonetti, C; Caraglia, M; De Rosa, G

Salzano, G; Zappavigna, S; Luce, A; D'Onofrio, N; Balestrieri, M L; Grimaldi, A; Lusa, S; Ingrosso, D; Artuso, S; Porru, M; Leonetti, C; Caraglia, M; De Rosa, G.

J Biomed Nanotechnol ; 12(4): 811-30, 2016 Apr.

Article in En | MEDLINE | ID: mdl-27301207

Subject(s)

Diphosphonates/administration & dosage; Glioblastoma/therapy; Imidazoles/administration & dosage; Nanocapsules/chemistry; Receptors, Transferrin/metabolism; Transferrin/metabolism; Transferrin/pharmacokinetics; Animals; Antineoplastic Agents/administration & dosage; Antineoplastic Agents/chemistry; Cell Line, Tumor; Cell Proliferation/drug effects; Cell Survival/drug effects; Diffusion; Diphosphonates/chemistry; Glioblastoma/pathology; Imidazoles/chemistry; Male; Mice; Mice, Nude; Molecular Targeted Therapy/methods; Nanocapsules/ultrastructure; Transferrin/chemistry; Treatment Outcome; Zoledronic Acid

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Receptors, Transferrin / Transferrin / Glioblastoma / Diphosphonates / Nanocapsules / Imidazoles Limits: Animals Language: En Journal: J Biomed Nanotechnol Year: 2016 Document type: Article Country of publication: United States

Search on Google

Add to My VHL

XML

PubMed Links